Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: An international collaborative meta-Analysis

European Journal of Surgical Oncology

Volumn 39, Issue 2, 2013, Pages 115-124

  Kim, H S ^a   Sardi, J E ^b   Katsumata, N ^c   Ryu, H S ^d   Nam, J H ^e   Chung, H H ^a   Park, N H ^a   Song, Y S ^a,f   Behtash, N ^g   Kamura, T ^h   Cai, H B ⁱ   Kim, J W ^a  

^a Seoul National University College of Medicine   (South Korea)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d Ajou University School of Medicine   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Seoul National University   (South Korea)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ WUHAN UNIVERSITY   (China)

Author keywords

Cervical cancer; Chemotherapy; Neoadjuvant; Surgery

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; MITOMYCIN; PACLITAXEL; VINCRISTINE;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DISEASE COURSE; DISTANT METASTASIS; DRUG EFFICACY; GYNECOLOGIC SURGERY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; REVIEW; TUMOR VOLUME; UTERINE CERVIX CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; INTERNATIONAL COOPERATION; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBSERVATION; ODDS RATIO; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84872140312     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.09.003     Document Type: Review

References (26)

1. National Comprehensive Cancer Network Cervical cancer clinical practice guidelines in oncology (V.I.) 2012 Available at: http://www.nccn.org [accessed June, 2012]
2. J.A. Green, J.M. Kirwan, and J.F. Tierney Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-Analysis Lancet 368 2011 781 786
3. D.H. Suh, K. Kim, and J.W. Kim Major clinical research advances in gynecologic cancer 2011 J Gynecol Oncol 23 2012 53 64
4. L. Rogers, S.S. Siu, D. Luesley, A. Bryant, and H.O. Dickinson Radiotherapy and chemoradiation after surgery for early cervical cancer Cochrane Database Syst Rev 5 2012 CD007583
5. H.S. Kim, J.Y. Kim, and N.H. Park Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer Gynecol Oncol 119 2010 217 224
6. J.E. Sardi, G.R. di Paola, and A. Cachau A possible new trend in the management of the carcinoma of the cervix uteri Gynecol Oncol 25 1986 139 149 (Pubitemid 16004351)
7. J.E. Sardi, A. Giaroli, and C. Sananes Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results Gynecol Oncol 67 1997 61 69 (Pubitemid 27433330)
8. U. Napolitano, F. Imperato, and B. Mossa The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial Eur J Gynaecol Oncol 24 2003 51 59 (Pubitemid 36268188)
9. H.B. Cai, H.Z. Chen, and H.H. Yin Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer J Obstet Gynaecol Res 32 2006 315 323
10. G.L. Eddy, B.N. Bundy, and W.T. Creasman Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-Aortic lymphadenectomy: a phase III trial of the gynecologic oncology group Gynecol Oncol 106 2007 362 369 (Pubitemid 47087936)
11. N. Katsumata, H. Yoshikawa, and H. Kobayashi Phase III randomized trial of neoadjuvant chemotherapy (NAC) followed by radical hysterectomy (RH) versus RH for bulky stage I/II cervical cancer: update of Japan Clinical Oncology Group (JCOG) protocol 0102 J Clin Oncol 28 Suppl. 2010 5047
12. N. Behtash, Z. Nazari, H. Ayatollahi, M. Modarres, F. Ghaemmaghami, and A. Mousavi Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer Eur J Surg Oncol 32 2006 1226 1230 (Pubitemid 44774409)
13. H.S. Ryu, S.B. Kang, K.T. Kim, K.H. Chang, J.W. Kim, and J.H. Kim Efficacy of different types of treatment in FIGO stage IB2 cervical cancer in Korea: results of a multicenter retrospective Korean study (KGOG-1005) Int J Gynecol Cancer 17 2007 132 136 (Pubitemid 46213981)
14. Y.H. Cho, D.Y. Kim, J.H. Kim, Y.M. Kim, Y.T. Kim, and J.H. Nam Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer J Gynecol Oncol 20 2009 22 27
15. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-Analysis Collaboration Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-Analysis of individual patient data from 21 randomised trials Eur J Cancer 39 2003 2470 2486
16. L. Rydzewska, J. Tierney, C.L. Vale, and P.R. Symonds Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer Cochrane Database Syst Rev 1 2010 CD007406
17. M.A. Quinn, J.L. Benedet, and F. Odicino Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer Int J Gynaecol Obstet 95 Suppl. 1 2006 S43 S103
18. A. Liberati, D.G. Altman, and J. Tetziadd The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate health care interventions: explanation and elaboration PLos Med 6 2009 e1000100
19. H.S. Kim, W. Ju, and B.C. Jee Systematic lymphadenetomy for survival in epithelial ovarian cancer: a meta-Analysis Int J Gynecol Cancer 20 2010 520 528
20. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-Analyses BMJ 327 2003 557 560 (Pubitemid 37088507)
21. J. Guirguis-Blake, N. Calonge, T. Miller, A. Siu, S. Teutsch, E. Whitlock U.S. Preventive Services Task Force Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development Ann Intern Med 147 2007 117 122 (Pubitemid 351664614)
22. J.L. Alcázar, M. Jurado, and G. López-García Tumor vascularization in cervical cancer by 3-dimensional power Doppler angiography: correlation with tumor characteristics Int J Gynecol Cancer 20 2010 393 397
23. A.C. Testa, G. Ferrandina, and M. Distefano Color Doppler velocimetry and three-dimensional color power angiography of cervical carcinoma Ultrasound Obstet Gynecol 24 2004 445 452 (Pubitemid 39179483)
24. K. Kim, M.J. Kim, and H.H. Chung Inadvertent potential risk of neoadjuvant chemotherapy in cervical cancer Med Hypotheses 73 2009 1005 1007
25. M. Matsumura, N. Takeshima, and T. Ota Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for stage IB2-IIB cervical cancer-irinotecan and platinum chemotherapy Gynecol Oncol 119 2010 212 216
26. H.S. Kim, J.H. Kim, and H.H. Chung Significance of numbers of metastatic and removed lymph nodes in FIGO stage IB1 to IIA cervical cancer: primary surgical treatment versus neoadjuvant chemotherapy before surgery Gynecol Oncol 121 2011 551 557